TickerFacts.

Baird Medical Investment Holdings Ltd (BDMD): Capital Expenditures

Annual figures by period end, from SEC filings.

$42.3K
Year ended 2025-12-31
-80.7%
3-year compound annual growth
$5.91M2022-12-31: $5.91M2023-12-31: $2.64M2024-12-31: $2.85M2025-12-31: $42.3K$42.3K
2022-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$42.3K-98.5%2026-07-27, From 2025-01-01
2024-12-31$2.85M+8.2%2026-07-27, From 2024-01-01
2023-12-31$2.64M-55.4%2026-07-27, From 2023-01-01
2022-12-31$5.91Mn/a2025-05-15, From 2022-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Baird Medical Investment Holdings Ltd (BDMD)2025-12-31$42.3K-98.5%
DarioHealth Corp. (DRIO)2025-12-31$142.0K+2.9%
Sonoma Pharmaceuticals, Inc. (SNOA)2026-03-31$192.0K+140.0%
Nephros Inc (NEPH)2024-12-31$55.0K-26.7%
Sensus Healthcare, Inc. (SRTS)2025-12-31$196.0K-29.0%
Vivos Therapeutics, Inc. (VVOS)2025-12-31$2.34M+312.1%
Profound Medical Corp. (PROF)2025-12-31$176.0Kn/a
Premier Air Charter Holdings Inc. (PREM)2025-12-31$2.55M+70.8%
Allurion Technologies, Inc. (ALUR)2024-12-31$611.0K-62.0%

Compare BDMD, DRIO, SNOA, NEPH side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗